Aleksandra Filipovic, Amir Fathi, Noah Merin, Keri Maher, Rabin Niroula, Dale Schaar, Guenther Koehne, Joseph Maly, Jay Yang, Deepa Jeyakumar. "A phase I dose escalation and expansion trial of lyt-200 (a First-In-Class Anti-Galectin-9 Antibody) alone and in combination with venetoclax/HMA in Relapsed/Refractory AML/MDS." Blood, 2025. doi:10.1182/blood-2025-1648